The mesh nebuliser: a recent technical innovation for aerosol delivery

L Vecellio - Breathe, 2006 - Eur Respiratory Soc
Key points Mesh nebulisers can be used to nebulise aqueous drugs and suspensions;
however, with suspensions, there can be a reduction in performance in terms of aerosol output …

Nebulization as a delivery method for mAbs in respiratory diseases

R Respaud, L Vecellio, P Diot… - Expert opinion on drug …, 2015 - Taylor & Francis
… Immunoglobulin monomers consist of two light (L) chains (25 kDa) and two heavy (H) chains
(55 kDa) arranged in a Y-shape. The light chains interact with the amino-terminal part of the …

Aerosol therapy in adults receiving high flow nasal cannula oxygen therapy

F Réminiac, L Vecellio, N Heuzé-Vourc'h… - Journal of aerosol …, 2016 - liebertpub.com
… eg, a mean flow rate of 15 L/min that was used to simulate quiet breathing in our study)
promotes aerosol losses at a HFT flow rate of 30 to 60 L/min (ie, higher than 15 L/min) because of …

Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel

J Hureaux, F Lagarce, F Gagnadoux, L Vecellio… - European journal of …, 2009 - Elsevier
… ) operating at an airflow rate of 12.0 l/min. The duration of the … at an airflow rate of 12.0 l/min.
Volumes of nebulised … of droplets at a flow rate of 15.0 l/min. The deposited aerosol on each …

Nasal high flow nebulization in infants and toddlers: an in vitro and in vivo scintigraphic study

F Réminiac, L Vecellio, RM Loughlin… - Pediatric …, 2017 - Wiley Online Library
… 8 L/min (combination of 6 L/min gas driving the jet nebulizer with 2 L/min NHF flow-rate or 8
L/… Beyond high gas flow driven aerosol impaction (6 L/min jet nebulization plus 2 L/min NHF …

[HTML][HTML] Aerosol deposition in neonatal ventilation

JC Dubus, L Vecellio, M De Monte, JB Fink… - Pediatric …, 2005 - nature.com
… The MistyNeb was driven by oxygen at a flow of 6 L/min. The VMD produced by MistyNeb
was 4.6 μm (Spraytech, Malvern, UK). Maintenance of ventilator parameters required …

Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?

E Bodier-Montagutelli, A Mayor, L Vecellio… - Expert opinion on …, 2018 - Taylor & Francis
L Vecellio is an employee of Nemera, a medical device company. English writing assistance,
provided by David Fraser, Biotech Communication, was utilized in the production of this …

In vitro–in vivo correlation of intranasal drug deposition

S Le Guellec, S Ehrmann, L Vecellio - Advanced Drug Delivery Reviews, 2021 - Elsevier
In vitro – in vivo correlation (IVIVC) allows prediction of in vivo drug deposition from a nasally
inhaled drug based on in vitro drug measurements. In vitro measurements include physical …

Innovative preclinical models for pulmonary drug delivery research

…, L Yang, H Barosova, L Vecellio… - Expert opinion on …, 2020 - Taylor & Francis
Introduction: Pulmonary drug delivery is a complex field of research combining physics which
drive aerosol transport and deposition and biology which underpins efficacy and toxicity of …

Effect of formulation on the stability and aerosol performance of a nebulized antibody

…, MC Viaud-Massuard, P Diot, M Si-Tahar, L Vecellio… - MAbs, 2014 - Taylor & Francis
… The aerosol droplets were aspirated by a constant suction pump at an airflow rate of 20 l/minute,
on the opposite side of the aerosol beam. All experiments were performed at room …